There is a risk of mild diarrhoea, upset stomach, nausea, a feeling of pain and warm sensation at the site of the injection, a feeling or a sense of being swollen over the entire body, headache and joint pain
Lindsay Fowler Dragos, MD
Clear any nasal congestion: Before administering the peptide via spray, clear the nasal membrane
The Phase 2 trial results Published in the New England Journal of Medicine, the Phase 2 trial showed that participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean weight reduction of 24.2% at 48 weeks
This turnover produces byproducts that must be excreted
Theres a lot of mixed information out there, making it hard to separate fact from fiction